All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityABBs-Block Trades

Boehringer Ingelheim exits Hikma Pharmaceuticals


German pharmaceuticals company Boehringer Ingelheim has sold its remaining stake in UK drug maker Hikma Pharmaceuticals, after a surge in investor interest in pharma stocks during the Covid-19 global pandemic.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree